Drug therapy of rheumatic disorders in the light of European and worldwide experience
Trnavský, K.; Pavelka, K.; Pavelka, K.
Vnitrni Lekarstvi 33(1): 48-52
1987
ISSN/ISBN: 0042-773X PMID: 3493584 Document Number: 295760
Document emailed within 1 workday
Related Documents
Simon, B.; Leucht, U.; Amon, I.; Brandau, J.; Müller, P. 1993: Nizatidine in therapy and prevention of non-steroidal anti-rheumatic drug-induced ulcers in rheumatic patients Zeitschrift für Gastroenterologie 31(6): 395-400Menninger, H.; Burkhardt, H. 1983: Long-term drug therapy in inflammatory rheumatic diseases using chronic polyarthritis as an example. 2. Basic principles of long-term drug therapy: choice of optimal therapeutic agents Fortschritte der Medizin 101(14): 639-645
Chlud, K. 1975: Drug therapy of rheumatic diseases Die Medizinische Welt 26(45): 2044-2050
Berlin, I.I. 1976: Clinical aspects and therapy of rheumatic disorders of the nervous system Fel'dsher i Akusherka 41(5): 31-36
Wils, J. 2001: Adjuvant therapy for colon cancer: the European experience Tumori 87(1 Suppl 1: S85
Accardo, S.; Traverso, A.; Caraffa, M.; Ferretti, A.; Moreno, M. 1978: Use of a new non-steroid, anti-inflammatory drug, ketoprofen, in the therapy of rheumatic diseases Minerva Medica 69(51): 3523-3530
Keller, M.B. 2000: Citalopram therapy for depression: a review of 10 years of European experience and data from U.S. clinical trials Journal of Clinical Psychiatry 61(12): 896-908
Neumann, H.A. 1992: Socioeconomic aspects of phlebologic disorders in the Benelux countries. European standardization of pressure therapy using the compression stocking Phlebologie 45(4): 453-454
Matsumoto, T.; Kobayashi, O. 2010: Psycho-social therapy of disorders of psychotropic drug use: with special reference to cognitive behavior therapy to prevent repeated abuse Seishin Shinkeigaku Zasshi 112(7): 672-676
Greco, C.; Castiglioni, S.; Fodor, A.; Mazzetta, C.; De Cobelli, O.; Orecchia, R. 2004: Androgen ablation therapy does not increase the risk of late morbidity following 3D-conformal radiotherapy of organ-confined prostate cancer: the experience of the European Institute of Oncology Tumori 90(6): 567-572
Jia, B. 1995: Drug therapy of gastrointestinal motility disorders Zhonghua Nei Ke Za Zhi 34(3): 151-152
Cugurra, F. 1995: Drug therapy and affective disorders: state of the art La Clinica Terapeutica 146(10): 577-585
Benvenuti, C.; Guerini Rocco, C.; Trezzi, P. 1995: Nationwide drug surveillance project on slow-release nicardipine in the short-term therapy of light/moderate arterial hypertension Minerva Cardioangiologica 43(9): 399-408
Madersbacher 1978: Conservative drug therapy of neurogenic bladder disorders Helvetica Chirurgica Acta 45(3): 237-245
Dougados, M.; Torley, H. 1993: Efficacy of cyclosporin a in rheumatoid arthritis: worldwide experience British Journal of Rheumatology 32(Suppl 1): 57-59
Faust-Tinnefeldt, G.F.; Geissler, H.E. 1978: Azapropazone and rheumatic combination therapy considering drug interactions: azapropazone aurothioglucose and azapropazone prednisolone Arzneimittel-Forschung 28(2): 337-341
Kaur, S.; Sharma, V.K.; Kumar, B.; Singh, M.; Kaur, I. 1985: Multi-drug therapy in bacilliferous leprosy--two years experience Indian Journal of Leprosy 57(3): 483-490
Keirse, M.J. 1993: Prostaglandins in preinduction cervical ripening. Meta-analysis of worldwide clinical experience Journal of Reproductive Medicine 38(1 Suppl): 89-100
Sasaki, Y.; Kurashima, A.; Morimoto, K.; Okumura, M.; Watanabe, M.; Yoshiyama, T.; Ogata, H.; Gotoh, H.; Kudoh, S.; Suzuki, H. 2014: Experience of rapid drug desensitization therapy in the treatment of mycobacterial disease Kekkaku: 89(11): 797-802
Niehues, T.; Horneff, G.; Michels, H.; Sailer Höck, M.; Schuchmann, L. 2004: Evidence-based use of methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany (AGKJR) and the Working Group Pediatric Rheumatology Austria Zeitschrift für Rheumatologie 63(2): 147-158